Insulin resistance and increased pancreatic β-cell proliferation in mice expressing a mutant insulin receptor (P1195L)

17Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Several mutations of the tyrosine kinase domain of insulin receptor (IR) have been clinically reported to lead insulin resistance and insulin hypersecretion in humans. However, it has not been completely clarified how insulin resistance and pancreatic β-cell function affect each other under the expression of mutant IR. We investigated the response of pancreatic β-cells in mice carrying a mutation (P1195L) in the tyrosine kinase domain of IR β-subunit. Homozygous (IrP1195L/P1195L) mice showed severe ketoacidosis and died within 2 days after birth, and heterozygous (IrP1195L/wt) mice showed normal levels of plasma glucose, but high levels of plasma insulin in the fasted state and after glucose loading, and a reduced response of plasma glucose lowering effect to exogenously administered insulin compared with wild type (Irwt/wt) mice. There were no differences in the insulin receptor substrate (IRS)-2 expression and its phosphorylation levels in the liver between IrP1195L/wt and Irwt/wt mice, both before and after insulin injection. This result may indicate that IRS-2 signaling is not changed in IrP1195L/wt mice. The β-cell mass increased due to the increased numbers of β-cells in IrP1195L/wt mice. More proliferative β-cells were observed in IrP1195L/wt mice, but the number of apoptotic β-cells was almost the same as that in Irwt/wt mice, even after streptozotocin treatment. These data suggest that, in IrP1195L/wt mice, normal levels of plasma glucose were maintained due to high levels of plasma insulin resulting from increased numbers of β-cells, which in turn was due to increased β-cell proliferation rather than decreased β-cell apoptosis. © 2006 Society for Endocrinology.

References Powered by Scopus

Role of insulin resistance in human disease

11645Citations
N/AReaders
Get full text

Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice

1718Citations
N/AReaders
Get full text

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)

1619Citations
N/AReaders
Get full text

Cited by Powered by Scopus

High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets

90Citations
N/AReaders
Get full text

Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms

58Citations
N/AReaders
Get full text

A novel model of diabetic complications: Adipocyte mitochondrial dysfunction triggers massive β-cell hyperplasia

43Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ogino, J., Sakurai, K., Yoshiwara, K., Suzuki, Y., Ishizuka, N., Seki, N., … Saito, Y. (2006). Insulin resistance and increased pancreatic β-cell proliferation in mice expressing a mutant insulin receptor (P1195L). Journal of Endocrinology, 190(3), 739–747. https://doi.org/10.1677/joe.1.06849

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

89%

Researcher 1

11%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

45%

Medicine and Dentistry 4

36%

Biochemistry, Genetics and Molecular Bi... 1

9%

Social Sciences 1

9%

Save time finding and organizing research with Mendeley

Sign up for free